Triple negative and basal-like breast cancer in East Africa

Breast Journal

Volumn 17, Issue 4, 2011, Pages 438-440

  Trinkaus, Mateya E ^a   Sayed, Shahin ^b   Gakinya, Samuel Mukono ^b   Moloo, Zahir ^b   Hanna, Wedad ^c   Rahim, Yasmin ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AGA KHAN UNIVERSITY   (Kenya)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d Stronach Regional Cancer Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AFRICA; BASAL LIKE BREAST CANCER; BREAST CANCER; CANCER INCIDENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; HEALTH CARE ACCESS; HUMAN; IMMUNOHISTOCHEMISTRY; KENYA; LETTER; PROTEIN EXPRESSION; RISK FACTOR; SOCIAL STATUS; TANZANIA; TRIPLE NEGATIVE BREAST CANCER; UGANDA;

AFRICA, EASTERN; BREAST NEOPLASMS; FEMALE; HUMANS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 79960394230     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2011.01096.x     Document Type: Letter

References (21)

1. SÃrlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869.
2. Nofech-Mozes S, Trudeau M, Kahn HK, et al. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers. Breast Cancer Res Treat 2009; 118: 131-7.
3. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007; 13: 4429.
4. Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003; 95: 1482.
5. Atchley DP, Albarracin CT, Lopez A, et al. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 2008; 26: 4282.
6. Young S, Pilarski RT, Donenberg T, et al. The prevalence of BRCA 1 mutations among young women with triple-negative breast cancer. BMC Cancer 2009; 9: 86.
7. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492.
8. Lund MJB, Butler EN, Bumpers HL, et al. High prevalence of triple negative tumors in an urban cancer center. Cancer 2008; 113: 608-15.
9. Stark A, Kleer CG, Martin I, et al. African ancestry and higher prevalence of triple negative breast cancer. Cancer 2010; 116: 4926-32.
10. Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009; 27: 4515.
11. Gakinya S, Sayed S, Chauhan R, Sayed P,. Breast cancer molecular subtypes and their clinicopathological characteristics amongst patients at the Aga Khan University hospital (Nairobi). Ann Afr Surg 2010; 5: 19-24.
12. Bird P, Hill A, Houssami N,. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol 2008; 15: 1983-8.
13. Reddy JC, Reimann JD, Anderson SM, Klein PM,. Concordance between central and local laboratory HER2 testing from a community-based clinical study. Clin Breast Cancer 2006; 7: 153-7. (Pubitemid 44044012)
14. Nyagol J, Nyong'o A, Byakika B, et al. Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer. Anal Quant Cytol Histol 2006; 28: 97.
15. Roy I, Othieno E,. Breast carcinoma in Uganda: microscopic study and receptor profile of 45 cases. Arch Pathol Lab Med 2011; 135: 194-9.
16. Nalwoga H, Arnes JB, Wabinga H, Akslen LA,. Frequency of the basal like phenotype in African breast cancer. APMIS 2007; 115: 1391-9.
17. Gordon NH,. Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 2003; 22: 55-65. (Pubitemid 36363514)
18. Stalsberg H, Awuah B, Ibarra JA, Nsiah-Asare A, Reestablishing a surgical pathology service in Kumasi, Ghana: case report and discussion of barriers and key elements of a successful collaboration between low- and high-resource countries. Cancer. 2008; 113 (Suppl. 8): 2338-46.
19. Masood S, Vass L, Ibarra JA Jr, et al. Breast pathology guideline implementation in low and middle income countries. Cancer 2008; 113: 2297-304.
20. Mbonde M, Amir H, Schwartz-Albiez R, Akslen L, Kitinya J,. Expression of estrogen and progesterone receptors in carcinomas of the female breast in Tanzania. Oncol Rep 2000; 7: 277-83.
21. Burson AM, Soliman AS, Ngoma TA, et al. Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Disease 2010; 31: 33-41.